1. Clinical Overview
Xylometazoline is a potent, direct-acting sympathomimetic amine used as a topical nasal decongestant. The 0.01% w/v concentration is specifically formulated for pediatric use. It is an alpha-2 adrenergic receptor agonist that causes vasoconstriction of the dilated arterioles in the nasal mucosa, leading to reduced blood flow, decreased edema, and relief of nasal congestion. It has a rapid onset and a relatively long duration of action compared to other topical decongestants.
| Onset | Duration | Bioavailability |
|---|---|---|
| 5 to 10 minutes | 8 to 12 hours | Negligible systemic absorption following topical nasal administration (<1%). |
2. Mechanism of Action
Xylometazoline is a selective alpha-2 adrenergic receptor agonist. It acts locally on alpha-adrenergic receptors in the vascular smooth muscle of the nasal mucosa. Stimulation of these receptors activates the G-protein coupled pathway, leading to increased intracellular calcium levels. This results in sustained vasoconstriction of the dilated arterioles and capacitance vessels (venous sinusoids) within the nasal turbinates and mucosa.
3. Indications & Uses
- Symptomatic relief of nasal congestion associated with allergic rhinitis (seasonal/perennial)
- Symptomatic relief of nasal congestion associated with the common cold
- Symptomatic relief of nasal congestion associated with sinusitis
4. Dosage & Administration
Adult Dosage: Not indicated for adults at this strength. Use 0.1% w/v formulation.
Administration: 1. Clear nasal passages gently before use. 2. Tilt head slightly back. 3. For drops: Instill prescribed drops without touching dropper to nostril. 4. For spray: Insert tip into nostril, point away from nasal septum, and spray while breathing in gently. 5. Avoid sneezing or blowing nose immediately after administration. 6. Rinse dropper/spray tip with hot water after use.
5. Side Effects
Common side effects may include:
- Transient mild burning, stinging, or dryness of nasal mucosa
- Sneezing
- Mild headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) - e.g., Phenelzine, Tranylcypromine | Potentiates pressor effects, risk of severe hypertensive crisis. | Contraindicated |
| Tricyclic Antidepressants (TCAs) - e.g., Amitriptyline | May potentiate pressor effects of xylometazoline. | Major |
| Other Sympathomimetics (Oral decongestants - Pseudoephedrine, Phenylephrine) | Additive adrenergic effects, increasing risk of hypertension, tachycardia, and CNS stimulation. | Major |
| Beta-blockers (non-selective) - e.g., Propranolol | Unopposed alpha-adrenergic stimulation can lead to severe hypertension and bradycardia. | Major |
| Methyldopa | May potentiate pressor response. | Moderate |
| Ergot Alkaloids (e.g., Ergotamine) | Increased risk of peripheral ischemia and severe vasoconstriction. | Major |
7. Patient Counselling
- DO use exactly as prescribed, not more frequently or for longer than 5 days.
- DO clear your nose gently before administration.
- DO clean the dropper or spray tip with hot water after each use.
- DO NOT share the bottle with others to prevent infection.
- DO NOT allow the dropper/spray tip to touch your nostril or any surface.
- DO NOT use if the solution is discolored or contains particles.
- DO NOT exceed the recommended dose, especially in children.
8. Toxicology & Storage
Overdose: In children: Profound CNS depression (lethargy, sedation, hypothermia, coma), bradycardia, respiratory depression, apnea. In adults: Hypertension, tachycardia, cardiac arrhythmias, headache, nervousness, insomnia, tremors, pallor, sweating, nausea. Severe cases: Hypertensive crisis, intracranial hemorrhage, pulmonary edema, cardiovascular collapse.
Storage: Store at room temperature (15-25°C), protected from light and moisture. Do not freeze. Keep the bottle tightly closed. Keep out of reach and sight of children. Discard any unused medicine 30 days after opening the container.